+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

From
Sarcopenia Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Sarcopenia Market Insight, Epidemiology and Market Forecast - 2032

  • Drug Pipelines
  • January 2024
  • 136 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast - 2032 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast - 2032

  • Report
  • January 2024
  • 106 Pages
  • Global
From
FASENRA (Benralizumab) Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FASENRA (Benralizumab) Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • September 2022
  • 30 Pages
  • Global
From
Chronic Refractory Cough (CRC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Refractory Cough (CRC) - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 77 Pages
  • Global
From
From
Idiopathic Pulmonary Fibrosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 109 Pages
  • Global
From
From
From
Alpha- Antitrypsin Deficiency - Epidemiology Forecast to 2032 - Product Thumbnail Image

Alpha- Antitrypsin Deficiency - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Sarcopenia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Sarcopenia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more